Eriko Hashimoto
About Eriko Hashimoto
Eriko Hashimoto is the Associate Director of Marketing for the Immunology Franchise at Bristol Myers Squibb in Tokyo, Japan, with extensive experience in the Japanese and Australian pharmaceutical markets.
Current Title and Role at Bristol Myers Squibb
Eriko Hashimoto is currently serving as the Associate Director, Marketing, Immunology Franchise, within the Innovative Medicines Business Unit at Bristol Myers Squibb, based in Tokyo, Japan. In this role, she oversees marketing strategies and initiatives focused on the immunology segment, applying her extensive knowledge and expertise in pharmaceutical marketing.
Work History at Bristol Myers Squibb
Eriko Hashimoto has a long-standing history with Bristol Myers Squibb, having served in various capacities over more than 15 years. Her roles have included Product Manager in both Tokyo, Japan, and Melbourne, Australia, from 2005 to 2010 and 2005 to 2015, respectively. She then served as Business Insights & Analytics Manager from 2015 to 2017, and later as Manager, Business Development and Alliance Management, Corporate Partnership from 2020 to 2021 in Tokyo, Japan.
Experience at the Japan Pharmaceutical Manufacturers Association (JPMA)
From 2017 to 2020, Eriko Hashimoto was a Research Fellow at the Office of Pharmaceutical Industry Research within the Japan Pharmaceutical Manufacturers Association (JPMA). During her three-year tenure, she conducted extensive research focused on the pharmaceutical industry, contributing to the body of knowledge in Japan's pharmaceutical sector.
Expertise and Geographic Experience
Eriko Hashimoto boasts significant experience in the pharmaceutical markets of both Japan and Australia. Her extensive tenure at Bristol Myers Squibb and her research fellowship at JPMA highlight her deep understanding of both regional markets. She has developed robust marketing strategies and managed product portfolios, further showcasing her expertise.
Transition within Bristol Myers Squibb
Eriko Hashimoto has demonstrated remarkable adaptability and growth within Bristol Myers Squibb by transitioning through various roles. After her stint as Business Insights & Analytics Manager from 2015 to 2017, she moved into Business Development and Alliance Management from 2020 to 2021. This progression underscores her ability to adapt and take on new challenges within the pharmaceutical industry.